Vivo Capital, LLC Geron Corp Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
A detailed history of Vivo Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Vivo Capital, LLC holds 27,225,292 shares of GERN stock, worth $109 Million. This represents 18.09% of its overall portfolio holdings.
Number of Shares
27,225,292
Previous 27,225,292
-0.0%
Holding current value
$109 Million
Previous $115 Million
7.07%
% of portfolio
18.09%
Previous 17.06%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
275Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$187 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$177 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$130 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$130 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$116 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.52B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...